PMFA
PPH icon

Plante Moran Financial Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Plante Moran Financial Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed -$5K – 996
2016
Q4 		$5K Buy
+100
New +$5.34K ﹤0.01% 722

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return
CC
Colrain Capital Boston, Massachusetts $259M AUM 63.6% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Plante Moran Financial Advisors's PPH Position: Q1 2017 in Review

Plante Moran Financial Advisors sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2017, closing a stake of 100 shares — an estimated $5K sold.

Plante Moran Financial Advisors first reported a position in PPH in Q4 2016 and held it in 1 quarter. The position peaked at $5K in Q4 2016. 50 funds tracked by Wall St. Rank hold PPH as of Q1 2017.

  • Plante Moran Financial Advisors reported no remaining VanEck Pharmaceutical ETF position as of Q1 2017 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 100 VanEck Pharmaceutical ETF shares in Q1 2017, an estimated $5K.
  • Plante Moran Financial Advisors first reported a position in VanEck Pharmaceutical ETF in Q4 2016 and held it in 1 quarter.
  • Plante Moran Financial Advisors's VanEck Pharmaceutical ETF position peaked at $5K in Q4 2016.
  • 50 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2017.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2017, filed 1 May 2017.